{"id":"W2792717752","doi":"10.1016/j.eururo.2018.03.006","title":"Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"ca_institutions":"Kingston Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Willingness to pay; Bladder cancer; Cost effectiveness; Cancer; Internal medicine; Oncology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009631925,0.0004188795,0.001139002,0.0005315515,0.0001912352,0.0008602951,0.0003648404,0.000620158,0.002846376],"category_scores_gemma":[0.003018129,0.0001877104,0.002294686,0.0004839462,0.0001846863,0.000885707,0.000424882,0.001097639,0.0001219709],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002655467,"about_ca_system_score_gemma":0.0009958736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006291402,"about_ca_topic_score_gemma":0.00712865,"domain_scores_codex":[0.9994097,0.000310693,0.00004866331,0.00005616695,0.00007498564,0.00009988635],"domain_scores_gemma":[0.9992679,0.0003079576,0.000172223,0.00002163408,0.00004753509,0.0001827678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.2479945,0.004001844,0.1240962,0.004707864,0.01513879,0.0009724801,0.0001974845,0.04979998,0.004319544,0.002590235,0.006358026,0.5398231],"study_design_scores_gemma":[0.0361217,0.05958464,0.7625481,0.002478298,0.03182605,0.002886699,0.001017824,0.08245817,0.003370121,0.003215112,0.01432719,0.0001660251],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9627414,0.03108458,0.0003925495,0.001921297,0.0001780428,0.0001003875,0.0007614787,0.00002433738,0.002796093],"genre_scores_gemma":[0.9974316,0.001755293,0.0001432315,0.0001305834,0.00003666882,0.00002534947,0.000239674,0.00000247978,0.0002352253],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006291402,"threshold_uncertainty_score":0.01926678,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04143714961842677,"score_gpt":0.3442876869679283,"score_spread":0.3028505373495015,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}